$58 Million

Burning Rock Biotech Limited

Follow-on Offering

Bookrunner, December 2020

Burning Rock Biotech is a China-based cancer diagnostics company serving the Chinese market. The Company’s cancer therapy selection platform is built upon proprietary technologies, a comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through an in-hospital model and smaller hospitals through a central laboratory model.